Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05492240
Other study ID # 20-3068
Secondary ID R01AG072693
Status Recruiting
Phase N/A
First received
Last updated
Start date July 24, 2022
Est. completion date March 31, 2026

Study information

Verified date May 2024
Source University of Colorado, Denver
Contact Maggie Givan, MA
Phone 719.251.7533
Email maggie.givan@cuanschutz.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This cluster randomized clinical trial seeks to provide large-scale, foundational evidence that high-intensity rehabilitation is effective and can be systematically implemented to improve functional outcomes for patients admitted to skilled nursing facilities following hospitalization. Additionally, this study will generate a descriptive overview of factors that predict implementation success while informing effective implementation strategies for future skilled nursing facilities innovation.


Description:

In the U.S., 8.37 million adults over 65 will experience a hospital stay over the next year, which often has serious and long-lasting consequences including profound deterioration in physical function. Following a hospital stay, around 1.35 million patients with deconditioning require rehabilitation in a skilled nursing facility (SNF) each year to address the deleterious musculoskeletal and functional deficits from deconditioning. More than 64% of patients discharge from SNFs at functional levels that predispose them to adverse events, including rehospitalization, failing health, disability, institutionalization, or death. Physical function is a known modifiable predictor of these deleterious events, which can be addressed with rehabilitation. Therefore, more progressive and targeted musculoskeletal rehabilitation strategies that optimize physical function more effectively are needed. Therefore, the purpose of this study is to determine the effectiveness of a high-intensity rehabilitation approach (also referred to as i-STRONGER) at multiple skilled nursing facilities (SNFs), while evaluating characteristics of successful implementation through a rigorous, pragmatic cluster randomized controlled trial (16 Intervention SNFs vs 16 Usual Care SNFs). The investigators will promote high-intensity rehabilitation delivery to patients in an effort to address poor physical function outcomes. Specifically, the investigators will train rehabilitation clinicians at Intervention sites using distance-based instruction and collect study outcomes via the electronic medical record. Additionally, the investigators will gather quantitative and qualitative data (mixed methods) to evaluate processes, clinician-specific characteristics, and facility-specific contexts of implementation. The study methods seek to maximize successful reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) across Intervention sites. The implementation strategy is informed by the RE-AIM framework and integrated with educational and behavioral theories to facilitate clinical adoption of high-intensity rehabilitation.


Recruitment information / eligibility

Status Recruiting
Enrollment 2880
Est. completion date March 31, 2026
Est. primary completion date September 30, 2025
Accepts healthy volunteers No
Gender All
Age group 50 Years to 120 Years
Eligibility Rehabilitation staff at enrolled sites will participate in research activities, as indicated by group assignment. Site Inclusion Criteria: - Aegis Therapies-contracted skilled nursing facility (SNF) - Admits approximately 15 patients per month for short term rehabilitation Patient Inclusion Criteria: - At least 50 years of age - Admitted to a SNF from the hospital - Ambulatory upon SNF admission Patient Exclusion Criteria: - Contraindications to high-intensity resistance training, per American College of Sports Medicine Exercise Testing and Prescription - Lower extremity weight-bearing precautions - Neurological diagnosis (e.g., Cerebral vascular accident, Multiple Sclerosis, Parkinson's disease) - Subsequent SNF admission

Study Design


Related Conditions & MeSH terms


Intervention

Other:
i-STRONGER
An 8RM is the dose necessary for most effective strength gains in community-dwelling older adults, and is equivalent to 80% of a one repetition max, which is the maximal load needed to voluntarily complete one repetition of a given exercise with proper form. Clinicians will tailor the intervention for each activity, so the patient achieves 8 repetitions with failure on the 9th repetition. Failure is the inability to complete a repetition through the full, available range of motion without significant compensation. Further, high-intensity dosing requires continuous, volitional effort from the patient; therefore, incorporation of motivational interviewing strategies across sessions will maximize patient effort and self-efficacy.
Usual Care
Usual Care SNFs will continue with routine collection and documentation of physical performance outcomes (gait speed, SPPB, Modified Barthel ADL Index) as standard practice. Furthermore, a combination of chart reviews and on-site or remote observation will allow for characterization of usual care components for descriptive comparison. Importantly, the Usual Care SNF including the facility, rehabilitation clinicians, and patients will not have access to i-STRONGER materials.

Locations

Country Name City State
United States University of Colorado Denver, Anschutz Medical Campus Aurora Colorado
United States Aegis Therapies Frisco Texas

Sponsors (3)

Lead Sponsor Collaborator
University of Colorado, Denver Aegis Therapies, Inc., National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in Total Score Modified Barthel ADL Index (MBI) The Modified Barthel ADL Index assesses the ability to perform basic Activities of Daily Living (ADL) tasks. Total score range is 0-100. Total score is commuted by summing dependence across 10 ADL tasks: chair/bed transfers, ambulation, stair climbing, toilet transfers, bowel control, bladder control, bathing, dressing, personal hygiene (grooming), and feeding. Higher scores indicate increased independence. From date of admission into the SNF to date of discharge from the SNF, which would be an approximate average of 21 days
Other RE-AIM Component: Reach Proportion of patients treated with high-intensity rehabilitation out of all eligible patients. Up to 16 months
Other RE-AIM Component: Adoption Proportion of clinicians using high-intensity rehabilitation with at least 75% of eligible patients out of all trained clinicians at Intervention sites. Up to 16 months
Other RE-AIM Component: Implementation Proportion of completed high-intensity rehabilitation elements out of all intervention elements assessed by a fidelity checklist. Up to 16 months
Other RE-AIM Component: Maintenance Proportion of facilities that sufficiently completed high-intensity elements out of all intervention elements assessed by a fidelity checklist. Assessed from 16 months up to 22 months
Primary Change in Gait Speed Gait speed will be measured in meters/second using the time it takes to walk a 4-meter path at usual speed using a stopwatch. From date of admission into the SNF to date of discharge from the SNF, which would be an approximate average of 21 days
Secondary Change in Short Physical Performance Battery (SPPB) The SPPB is comprised of 3 tasks: a hierarchical standing balance test (side-by-side, semi-tandem, and tandem), a 4-meter usual gait speed, and a 5-time sit-to-stand from a standardized chair. Each subtask is scored (based on time) from 0-4 points and then summarized into a total score of 0-12 points, where 12 points represents the highest performance. From date of admission into the SNF to date of discharge from the SNF, which would be an approximate average of 21 days
Secondary Post-discharge Rehospitalization Rate The proportion of patients eligible for high-intensity rehabilitation who return to the hospital within 30 days of discharge from the SNF. From date of discharge from the SNF, assessed up to 30 days
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A